Effect of Local Corticosteroid Injection of the Hand and Wrist on Blood Glucose in Patients With Diabetes Mellitus
|
|
- Magnus Clark
- 5 years ago
- Views:
Transcription
1 Effect of Local Corticosteroid Injection of the Hand and Wrist on Blood Glucose in Patients With Diabetes Mellitus Louis W. Catalano III, MD; Steven Z. Glickel, MD; O. Alton Barron, MD; Richard Harrison, MD; Astrid Marshall, BA; Marissa Purcelli-Lafer, BA abstract Full article available online at Healio.com/Orthopedics. Search: Locally administered corticosteroids are a common therapy in many hand and wrist disorders. Corticosteroids pose a theoretical risk to patients with diabetes mellitus by potentially raising blood glucose to hyperglycemic levels. Although oral corticosteroids are known to have an effect on blood glucose control, limited data exist on extra-articular administration. The purpose of this study was to examine the systemic impact of extra-articularly administered corticosteroids in the hand and wrist on serum glucose concentration in patients with diabetes mellitus. Twenty-three patients with diabetes mellitus received a 1-mL triamcinolone acetonide injection for de Quervain s tenosynovitis, trigger finger, flexor carpi ulnaris tendonitis, or carpal tunnel syndrome. Patients recorded their daily morning blood glucose levels for 1 week before injection and for 4 weeks after injection. Average blood glucose levels increased slightly from baseline after injection, reaching statistical significance 1, 5, and 6 days after injection, but were not clinically significant (average increase, 14.2, 9.7, and 32.7 mg/dl, respectively). Isolated increases more than 2 times the standard deviation of preinjection values occurred at least once in the majority of patients. The frequency of hyperglycemic episodes increased after injection, but the proportions of patients with at least 1 hyperglycemic episode before and after injection were not significantly different. These results suggest that local corticosteroid injections are a clinically safe treatment option for inflammatory processes of the hand and wrist in patients with diabetes mellitus. On average, patients experienced slight increases in blood glucose after receiving an injection. Most experienced isolated increases substantially beyond baseline and isolated hyperglycemic effects, but these did not pose an apparent clinical risk. Drs Catalano, Glickel, Barron, and Harrison and Mss Marshall and Purcelli-Lafer are from the C.V. Starr Hand Surgery Center, New York, New York. Drs Catalano, Glickel, Barron, and Harrison and Mss Marshall and Purcelli-Lafer have no relevant financial relationships to disclose. Correspondence should be addressed to: Louis W. Catalano III, MD, C.V. Starr Hand Surgery Center, th Ave, New York, NY (cvstarr@gmail.com). doi: / e1754
2 Effect of Corticosteroid Injection on Blood Glucose Catalano et al Locally administered steroids are a common first-line therapy in many upper-extremity disorders, including trigger finger, dequervain s tenosynovitis, medial and lateral epicondylitis, bursitis, and rotator cuff tendonitis. Steroid injections have been shown to be efficacious in treating these problems and at times providing the definitive cure. 1-3 Patients with diabetes mellitus have a higher incidence of musculoskeletal disorders of the hand compared with age- and sex-matched controls. 4,5 These patients have been shown to have an increased incidence of trigger finger, with a 10% lifetime risk compared with 2.5% in healthy controls. 4,6 In addition to having a higher incidence of such conditions, patients with diabetes mellitus have been shown to be less responsive to steroid injections. 1,4,7,8 However, the first line of treatment is often local corticosteroid injection because of the ease of delivery and, presumably, low risk to the patient. However, corticosteroids pose a theoretical risk to patients with diabetes mellitus. Evidence exists that locally administered corticosteroids may have a systemic effect, which, in patient with diabetes mellitus, may result in elevated blood glucose levels. 9 Wang and Hutchinson 10 reported that a local injection of methylprednisolone in trigger fingers created a hyperglycemic effect that persisted for at least 5 days. They concluded that the transient effect was low risk when considering that corticosteroid injection prevented the need for surgery in nearly half of these patients. They recommended local steroid injection as the primary treatment of trigger finger in patients with diabetes mellitus. 10 The purpose of the current study was to further elucidate the systemic effect of extra-articularly administered corticosteroids in the hand and upper extremity on serum glucose concentration in patients with diabetes mellitus. After observing a patient with diabetes mellitus who became hyperglycemic (blood glucose more than 500 mg/dl) after receiving an extra-articular corticosteroid injection, the authors hypothesized that such events may occur with greater-than-expected frequency. Materials and Methods Fifty-four patients presenting with more than a 6-month history of insulin- and noninsulin-dependent diabetes mellitus who elected to receive a corticosteroid injection of the hand or wrist were included in the study s prospective cohort. Patients taking inhaled or oral steroids for other conditions, patients with a diagnosis of gestational diabetes only, and patients without blood glucose values for the week before injection recorded in a personal log were excluded. If not tested in the previous 30 days, hemoglobin A1c (HbA1c) was measured. Patients were injected with a combination of 1 ml of triamcinolone acetonide and 1 ml of 2% lidocaine, with the exception of 1 patient injected with 1 ml of triamcinolone acetonide and 3 ml of 2% lidocaine. Patients recorded their morning, noon, evening, and bedtime blood glucose levels for 1 week before injection and for 4 weeks after injection. Triamcinolone acetonide has been shown to have a serum half-life of 3.2 to 6.4 days and an average duration of action of 14 days. 11,12 Although a single intra-articular injection of 10 mg of triamcinolone acetonide was shown to be detectable in plasma for more than 2 weeks, data on the half-life of triamcinolone acetonide after extra-articular injection into the tendon sheath are limited 11 ; therefore, preferring not to cut the study period too short, the current authors set the postinjection observation period of this study for 4 weeks. All patients monitored their own blood glucose levels by finger stick with home monitoring devices. All patients administered their own medication, whether oral or insulin by injection. Patients did not specifically record whether blood glucose levels were preprandial vs postprandial. Because it is common when monitoring diabetes for patients to check their blood glucose before breakfast, 13 the authors understood the morning blood glucose values provided by patients to be fasting; however, they could not be certain. Institutional review board approval was obtained for this study. Informed consent and Health Insurance Portability and Accountability Act consent were obtained from each patient. Two main statistical analyses were performed. First, patients median preinjection morning blood glucose values were compared with their morning blood glucose values on each day after injection by Wilcoxon signed rank test for paired samples. Likewise, patients median preinjection bedtime blood glucose values were compared with their postinjection bedtime blood glucose values by Wilcoxon signed rank test for paired samples. However, this approach uses aggregate data, comparing averages, and the authors felt the data were too variable to reveal significance. As an alternate strategy to examine significant blood glucose increases for each patient as opposed to the aggregate data, the authors defined a significant postinjection increase as one more than 2 times the standard deviation of preinjection values, a strategy Habib and Miari 14 used to analyze blood glucose for increases after intra-articular injections of the knee. This way, one looks at each value for each patient and determines whether that value is significantly higher than that patient s baseline values. The frequency of such significant increases was documented. Second, hyperglycemic events (blood glucose more than 180 mg/dl, per clinical opinion of the endocrinology department) were considered to be clinically significant. The number of patients reporting a hyperglycemic episode at morning monitoring times during the 7 days before injection was compared with the number of patients reporting hyperglycemic events at morning monitoring times during the first 7 days after injection by chi-square test. Insulinand noninsulin-dependent study subgroups were compared by analysis of variance repeated measures. The a level for all statistical hypothesis tests was set at DECEMBER 2012 Volume 35 Number 12 e1755
3 Table Patient Data Parameter Value Average age (range), y 57 (34-71) Average baseline blood glucose level (range), mg/dl Morning 125 (91-201) Bedtime 153 ( ) Average preinjection HbA1c a (range) 6.6 ( ) No. men/women 9/14 No. insulin dependent 11 No. noninsulin dependent Diagnosis, No. 12 Trigger finger 12 dequervain s 8 Wrist tendonitis 2 Carpal tunnel syndrome Abbreviation: HbA1c, hemoglobin A1c. a Preinjection HbA1c was available for 12 of 23 patients. 1 A Results Twenty-seven (50%) patients returned completed datasheets. Four missing preinjection values were excluded because this rendered paired statistical analysis impossible. The Table shows patient demographics. No complications occurred from the injections. No patient stated that he or she required additional medication to compensate for elevated blood glucose levels during the study period. Blood glucose levels before and after injection are shown in the Figure. The highest preinjection blood glucose level was 424 mg/dl for insulin-dependent patients and 214 mg/dl for noninsulin-dependent patients, both at bedtime. The highest postinjection blood glucose level was 518 mg/dl for insulin-dependent patients and 264 mg/dl for noninsulin-dependent patients, also at bedtime. Pre- and postinjection blood glucose levels were notably B Figure: Average morning blood glucose levels (mg/dl) before and after injection for each day. The asterisk indicates statistically significant increases from preinjection values observed for day 1 (P5.046) and day 5 morning values (P5.034). Average bedtime blood glucose levels (mg/dl) before and after injection for each day. The asterisk indicates statistically significant increases from preinjection values observed for day 6 bedtime values (P5.045). Abbreviations: insulin-dependent (ID); NID, noninsulin-dependent. variable. Average preinjection HbA1c was 6.6%61.3%. Average morning blood glucose levels remained above preinjection values until 7 days after injection. However, statistically significant differences from preinjection values were noted on days 1 and 5 after injection (14.2 and 9.7 mg/dl, respectively; P5.046 and.034, respectively). Average bedtime blood glucose levels remained above preinjection values until day 10 after injection, and day 6 after injection showed a statistically significant difference (32.7 mg/dl; P5.045). For postinjection days with nonsignificant differences, a post hoc power analysis found that this sample had 80% power to detect a difference of at least 20 to 46 mg/dl from morning preinjection values and 31 to 93 mg/dl from bedtime preinjection values as statistically significant, depending on the day. Sixty-eight percent of patients experienced at least 1 significant blood glucose increase postinjection (defined as an increase more than 2 times the standard deviation of preinjection values), and 53% of patients experienced at least 1 significant increase resulting in a blood glucose level higher than 180 mg/dl. The timing of these increases was inconsistent, ranging from e1756
4 Effect of Corticosteroid Injection on Blood Glucose Catalano et al immediately after injection to 4 weeks thereafter. On average, 16% (range, 0%- 31%) of patients experienced significant increases each day. Because morning data were more complete, proportions of patients experiencing at least 1 hyperglycemic event (higher than 180 mg/dl) at morning monitoring 1 week before and after injection were compared, and no significant difference was found (P5.64). However, the sample was underpowered for this comparison. Forty-three percent (10/23) of patients experienced more hyperglycemic events after injection than before injection. Of these, only 4 did not report a blood glucose level higher than 180 mg/dl before injection. These patients, with baseline values consistently lower than 180 mg/dl, reported a range of 0.5 to 3 hyperglycemic events per postinjection week. The remaining 6 patients who experienced an increased frequency of hyperglycemic events after injection (4 to 5.75 events per postinjection week) were hyperglycemic at least once per preinjection week, with recent HbA1c levels of 6.2%, 6.4%, 7.1%, 7.2%, and 7.5%, respectively (1 patient was missing data). Insulin-dependent patients experienced greater changes from baseline than did noninsulin-dependent patients. Significant differences were found between these groups for only the first 2 weeks postinjection (P5.012), and a trend existed toward significance for the entire study period (P5.055). Discussion Patients with diabetes mellitus have a propensity for inflammatory conditions affecting the hand and wrist. The higher incidence of these problems in patients with diabetes mellitus than in the general population poses a challenge for treatment because the local steroids used to treat these conditions are less effective in patients with diabetes mellitus. 1,4,7,15 In addition, patients are often concerned about how these locally administered drugs may affect glycemic control. Oral corticosteroids are widely known to have systemic effects on blood glucose control, but data conflict on the effect of intra-articular administration and limited data for extra-articular administration. 16,17 Habib and Miari 14 recently examined the effect of 40 mg of triamcinolone injected intra-articularly in the knee and found significant increases in blood glucose among patients with diabetes mellitus. Even et al 18 reported significant increases in blood glucose levels after epidural injection. In the only other study of the effect of smaller dose, extra-articular injections on blood glucose level, Wang and Hutchinson 10 reported a significant spike in blood glucose level, averaging a 73% increase that persisted for 5 days postinjection. The current authors tested a different steroid formulation, and their results differed in that no pronounced spike was observed, only a small average increase. The difference in results may be due to several factors. The study by Wang and Hutchinson 10 did not require patients to record blood glucose measurements before injection, instead asking patients for usual morning and afternoon measurements (approximately 100 and 120 mg/dl, respectively). The current patients preinjection morning averages ranged from 94 to 201 mg/dl, and average HbA1c was 6.6%61.3%. The American Association of Clinical Endocrinologists (AACE) recommended a target of 6.5% or less for most nonpregnant adults with diabetes mellitus. 19 The current study s sample appears to have marginally suboptimal control, with higher baseline values and variability, rendering most average postinjection increases statistically insignificant. It is likely that the cohort s suboptimal control represents a more realistic clinical situation. In addition, different steroid medications were administered in the studies: the current study used 10 mg of triamcinolone acetonide and Wang and Hutchinson 10 used 10 mg of methylprednisolone acetate. These doses are of equivalent potency; however, methylprednisolone acetate and triamcinolone acetonide have been shown to have different durations of action (7 to 84 vs 14 days, respectively) and serum half-lives (5 to 8 vs 3.2 to 6.4 days, respectively) Therefore, the current results may not be comparable. Many of the current study s patients reported significant yet isolated increases from preinjection values. By defining a significant individual increase as more than 2 times the standard deviation of the patient s baseline, 14 these substantial increases should be beyond normal fluctuations, indicating that the injection may have had an effect. No more than 31% of patients observed these increases on any day postinjection, which explains the lack of statistically significant increases in aggregate data except on postinjection days 1, 5, and 6. However, those statistically significant average increases (14.2, 9.7, and 32.7 mg/dl, respectively) are not likely to be clinically significant. The primary concern regarding increased blood glucose is whether it results in hyperglycemia, defined here as higher than 180 mg/dl. More than half of the current patients reported at least 1 such instance of blood glucose level higher than 180 mg/dl preinjection. Three patients with such events both before and after injection had a HbA1c higher than the AACE-recommended target of 6.5%. 19 The highest, 7.5%, indicates a mean plasma glucose level of mg/dl 23 ; thus, it would not be unexpected for such patients sugars to fluctuate to higher than 180 mg/dl. Regardless of baseline control, 43% of the current patients were more frequently hyperglycemic after injection, indicating the injection may have a hyperglycemic effect. Insulin-dependent patients experienced greater increases from preinjection values than did noninsulin-dependent patients, and the groups were significantly different. This difference was expected because, in general, insulin-dependent patients have more difficulty controlling blood glucose than do noninsulin-dependent patients. 24 DECEMBER 2012 Volume 35 Number 12 e1757
5 This study had several weaknesses. The follow-up rate was lower than expected. Patients were supplied with stamped, addressed envelopes and were called to remind them to return the forms after their monitoring periods, but many failed to do so. Although patients were asked to record 4 blood glucose levels per day, patients did not reliably report all 4 and returned study forms with missing data, limiting the power of the analysis for bedtime levels. The comparison of morning values was sufficiently powered, detecting a difference of 46 mg/dl or less as significant on any given postinjection day. Although the authors suspect that patients reported morning blood glucose levels were recorded when fasting, this can not be confirmed definitively. However, the AACE and the American Diabetes Association do not specifically recommend in clinical practice guidelines that patients self-monitor before breakfast. They recommend self-monitoring at least 2 to 3 times daily and before injecting insulin, but the optimal timing is unclear. 19,23 Because selfmonitoring fasting glucose is not specifically recommended for diabetes care, the authors do not believe this detracts from the results. Furthermore, this study attempted to follow patients with diabetes mellitus controlling their glucose levels in daily life, analyzing paired data (using each patient as his or her own control). Patients monitored morning and bedtime postinjection sugars as they normally would, so it is unlikely that postinjection numbers would be skewed by a change in monitoring routine. Conclusion Despite being less effective in patients with diabetes mellitus vs controls, steroid injections play an important role in the treatment of disease in patients with diabetes mellitus. The initial hypothesis of this study, that patients with diabetes mellitus may routinely become hyperglycemic after extra-articular corticosteroid injection, was not proven. The results indicate that local steroid injections for inflammatory processes of the hand and wrist in patients with diabetes mellitus are a clinically safe treatment option with respect to glycemic control. Despite an increased frequency of hyperglycemic events and isolated, significant individual increases, these sporadic events are unlikely to pose a significant risk to the patient. On administering local steroid injections of triamcinolone acetonide in the hand and wrist, physicians should advise patients that they may experience occasional increases in blood glucose during the month following injection, but such increases are usually isolated and are expected to resolve within a day. References 1. Nimigan AS, Ross DC, Gan BS. Steroid injections in the management of trigger fingers. Am J Phys Med Rehabil. 2006; 85(1): Hay EM, Paterson SM, Lewis M, Hosie G, Croft P. Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care. BMJ. 1999; 319(7215): Stahl S, Kaufman T. The efficacy of an injection of steroids for medial epicondylitis. A prospective study of sixty elbows. J Bone Joint Surg Am. 1997; 79(11): Stahl S, Kanter Y, Karnielli E. Outcome of trigger finger treatment in diabetes. J Diabetes Complications. 1997; 11(5): Koh S, Nakamura S, Hattori T, Hirata H. Trigger digits in diabetes: their incidence and characteristics. J Hand Surg Eur Vol. 2010; 35(4): Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allien Y. Dupuytren s disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am. 1995; 20(1): Baumgarten KM, Gerlach D, Boyer MI. Corticosteroid injection in diabetic patients with trigger finger. A prospective, randomized, controlled double-blinded study. J Bone Joint Surg Am. 2007; 89(12): Griggs SM, Weiss AP, Lane LB, Schwenker C, Akelman E, Sachar K. Treatment of trigger finger in patients with diabetes mellitus. J Hand Surg Am. 1995; 20(5): Koehler BE, Urowitz MB, Killinger DW. The systemic effects of intra-articular corticosteroid. J Rheumatol. 1974; 1(1): Wang AA, Hutchinson DT. The effect of corticosteroid injection for trigger finger on blood glucose level in diabetic patients. J Hand Surg Am. 2006; 31(6): Derendorf H, Möllmann H, Grüner A, Haack D, Gyselby G. Pharmacokinetics and pharmacodynamics of glucorticoid suspensions after intra-articular administration. Clin Pharmacol Ther.1986; 39(3): Caldwell JR. Intra-articular corticosteroids: guide to selection and indications for use. Drugs. 1996; 52(4): Gearhart JG, Forbes RC. Initial management of the patient with newly diagnosed diabetes. Am Fam Physician. 1995; 51(8): , Habib GS, Miari W. The effect of intra-articular triamcinolone preparations on blood glucose levels in diabetic patients: a controlled study. J Clin Rheumatol. 2011; 17(6): Murphy D, Failla JM, Koniuch MP. Steroid versus placebo injection for trigger finger. J Hand Surg Am. 1995; 20(4): Younes M, Neffati F, Touzi M, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine. 2007; 74(5): Habib GS, Abu-Ahmad R. Lack of effect of corticosteroid injection at the shoulder joint on blood glucose levels in diabetic patients. Clin Rheumatol. 2007; 26(4): Even JL, Crosby CG, Sung Y, McGirt MJ, Devin CJ. Effects of epidural steroid injections on blood glucose levels in patients with diabetes mellitus. Spine (Phila Pa 1976). 2012; 37(1):E46-E Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011; 17(suppl 2): Chrousos GP. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, Masters SB, Trevor AT, eds. Basic and Clinical Pharmacology. 11th ed. New York, NY: McGraw Hill Medical; 2009: Cole BJ, Schumacher HR Jr. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg. 2005; 13(1): Skedros JG, Hunt KJ, Pitts TC. Variations in corticosteroid/anesthetic injections for painful shoulder conditions: comparisons among orthopaedic surgeons, rheumatologists, and physical medicine and primary-care physicians. BMC Musculoskelet Disord. 2007; 8: American Diabetes Association. Standards of medical care in diabetes Diabetes Care. 2012; 35(suppl 1):S11-S Davies M. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges. Int J Obes Relat Metab Disord. 2004; 28(suppl 2):S14-S22. e1758
Hyperglycemia Associated with Non-oral and Locally Injected Corticosteroids
PL Detail-Document #271011 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER October 2011 Hyperglycemia
More informationORTHOPEDIC PRIMARY CARE Joint Injections in Primary Care. Jackson Orthopaedic Foundation
ORTHOPEDIC PRIMARY CARE Joint Injections in Primary Care Jackson Orthopaedic Foundation Joint Injections in Primary Care Kathleen A. Geier, DNP, NP, ONC A.J. Benham, DNP, NP, ONC kgeier@jacksonortho.org
More informationProfessor Lisa Stamp
Professor Lisa Stamp Rheumatologist University of Otago, Christchurch 8:30-9:25 WS #65: Joint Injection Techniques 9:35-10:30 WS #75: Joint Injection Techniques (Repeated) Joint/soft tissue corticosteroid
More informationMusculoskeletal corticosteroid use:
Musculoskeletal corticosteroid use: Types, Indications, Contraindications, Equivalent doses, Frequency of use and Adverse effects. Dr Jide Olubaniyi MBBS, FRCR Dr Sean Crowther MB BCh, MRCS, FRCR Dr Sukhvinder
More informationAspiration, Intra-articular and Soft Tissue Injections. MR KEWAL SINGH, MS(orth), FRCS(Eng)
Aspiration, Intra-articular and Soft Tissue Injections MR KEWAL SINGH, MS(orth), FRCS(Eng) Indications for Aspiration Haemarthrosis Septic arthritis Symptomatic relief of a large effusion Crystal-induced
More informationIntraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations.
Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S108-21. doi: 10.1097/PHM.0000000000000115. Intraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations.
More informationIntroduction to Ultrasound Guided Shoulder Injections. Alison Hall Consultant Sonographer Keele University Cannock Chase Hospital
Introduction to Ultrasound Guided Shoulder Injections Alison Hall Consultant Sonographer Keele University Cannock Chase Hospital Safe Robust Aim: to provide a service that is Cost effective To enable patients
More informationTrigger finger, or stenosing tenosynovitis, Corticosteroid Injections in the Treatment of Trigger Finger: A Level I and II Systematic Review
Corticosteroid Injections in the Treatment of Trigger Finger: A Level I and II Systematic Review Sheryl B. Fleisch, BS Kurt P. Spindler, MD Donald H. Lee, MD Ms. Fleisch is Medical Student, Vanderbilt
More informationGP practical procedures Joint and soft tissue injections. Dr Monica Gupta Dr Hilary Wilson Dr John Hunter
GP practical procedures Joint and soft tissue injections Dr Monica Gupta Dr Hilary Wilson Dr John Hunter Outline of talk Acute mono arthritis Pros & Cons of injections Regional problems Shoulder Knee Soft
More informationORTHOPAEDIC INJECTION AND ASPIRATION TECHNIQUES
ORTHOPAEDIC INJECTION AND ASPIRATION TECHNIQUES OAAPN October 20, 2016 David H. Sohn, JD MD Chief, Shoulder and Sports Medicine University of Toledo Medical Center When to aspirate? To rule out infection
More informationADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values - New Treatment Guidelines Will Now be Needed
529638DSTXXX10.1177/1932296814529638Journal of Diabetes Science and TechnologyKlonoff research-article2014 Editorial ADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values
More informationThe Efficacy of Steroid Injection in the Treatment of Trigger Finger
Original Article Clinics in Orthopedic Surgery 2012;4:263-268 http://dx.doi.org/10.4055/cios.2012.4.4.263 The Efficacy of Steroid Injection in the Treatment of Trigger Finger Benan M. Dala-Ali, MBBS, Amir
More informationOriginal Article. Methylprednisolone Acetate Injection Plus Casting Versus Casting Alone for the Treatment of de Quervain s Tenosynovitis
Original Article Methylprednisolone Acetate Injection Plus Casting Versus Casting Alone for the Treatment of de Quervain s Tenosynovitis Seyed Abdolhossein Mehdinasab MD 1, Seyed Amirmohammad Alemohammad
More informationEffectiveness of Corticosteroids in the Treatment of Lateral Epicondylosis
Journal of Sport Rehabilitation, 2012, 21, 83-88 2012 Human Kinetics, Inc. Effectiveness of Corticosteroids in the Treatment of Lateral Epicondylosis Kelli R. Snyder and Todd A. Evans Clinical Scenario
More informationWork Related Musculoskeletal Disorders
Work Related Musculoskeletal Disorders Upper Extremity Disorders Carpel tunnel syndrome Cubital tunnel syndrome Thoracic outlet syndrome Raynaud s syndrome (white finger) Rotator cuff syndrome DeQuervain
More informationGlycemic Variability:
Glycemic Variability: Do the Differences Make a Difference? Kim L Kelly, PharmD, BCPS, FCCP Define Variability VERY LOW GLYCEMIC VARIABILITY LOW GLYCEMIC VARIABILITY HIGH GLYCEMIC VARIABILITY So what s
More informationBenefits of Aspiration and Injection JOINT INJECTIONS. Injection Indications. Mechanism of Action 1/11/2016
Benefits of Aspiration and Injection JOINT INJECTIONS Mark Niedfeldt, M.D. Medical College of Wisconsin Decrease or resolution of pain Decrease or resolution of inflammation Decrease or resolution of effusion
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationHands on - Steroid Injections. Jan Schulz, MD Associate professor of medicine McGill University
Hands on - Steroid Injections Jan Schulz, MD Associate professor of medicine McGill University Disclosures Abbott Pharmaceuticals Amgen Roche Bristol-Myers Squibb Janssen Ortho Novartis Adult Rheumatology
More informationComparisonoftheShortTermTreatmentOutcomeamongWatchfulWaitingandSolubleandInsolubleCorticosteroidInjectionsinIdiopathicTriggerFinger
: H Orthopedic and Musculoskeletal System Volume 16 Issue 1 Version 1.0 Year 2016 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618
More informationS houlder problems are common, with up to 47% of adults
156 EXTENDED REPORT Two pragmatic trials of treatment for shoulder disorders in primary care: generalisability, course, and prognostic indicators E Thomas, D A W M van der Windt, E M Hay, N Smidt, K Dziedzic,
More informationInsulin Pump Therapy for Type 2
9501172-011 Insulin Pump Therapy for Type 2 Objective To show the effectiveness of CSII for insulin-taking type 2 patients Key Points Tight glycemic control decreases risk of diabetes-related complications
More informationWorkshop Hands on - Steroid Injections. Michael Stein MDCM, FRCP(C) Date: Nov
Workshop Hands on - Steroid Injections Michael Stein MDCM, FRCP(C) Date: Nov 26 2018 Disclosure of Commercial Support This program has received no financial support Faculty/Presenter Disclosures I am a
More informationManagement of upper limb in cerebral palsy. Dr Sameer Desai Pediatric Orthopedic Surgeon KEM, Ruby Hall, Sahyadri Hospital, Unique Childrens Hospital
Management of upper limb in cerebral palsy Dr Sameer Desai Pediatric Orthopedic Surgeon KEM, Ruby Hall, Sahyadri Hospital, Unique Childrens Hospital Importance of upper limb in CP Activities of daily living
More informationInitiating Insulin in Primary Care for Type 2 Diabetes Mellitus. Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre
Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre Outline How big is the problem? Natural progression of type 2 diabetes What
More informationErgonomics Glossary. Force The amount of physical effort a person uses to do a task.
Ergonomics Glossary Administrative controls Procedures used to reduce the duration, frequency, or severity of exposure to a hazard. They may include training, job rotation, and gradual introduction to
More information5/15/2018 DISCLOSURE OBJECTIVES. FLORIDA HOSPITAL ORLANDO Not for profit organization Acute care medical center 1,368 licensed beds BACKGROUND
DISCLOSURE PHARMACIST DIRECTED MANAGEMENT OF GLUCOCORTICOID INDUCED HYPERGLYCEMIA AT A LARGE COMMUNITY HOSPITAL Jill Zaccardelli, PharmD PGY1 Pharmacy Resident Florida Hospital Orlando Jill.Zaccardelli@flhosp.org
More informationCurrent Trends in Diagnosis and Management of Gestational Diabetes
Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives
More informationShockwave Therapies for Musculoskeletal Problems Useful Literature
Shockwave Therapies for Musculoskeletal Problems Useful Literature I have some 1600 references related to shockwave therapy. Those listed below are the main musculoskeletal related papers from 2005-07
More informationInitiation and Titration of Insulin in Diabetes Mellitus Type 2
Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.
More informationMUSCULOSKELETAL DISORDERS: THE BIGGEST JOB SAFETY PROBLEM. What Are Musculoskeletal Disorders
MUSCULOSKELETAL DISORDERS: THE BIGGEST JOB SAFETY PROBLEM What Are Musculoskeletal Disorders Every year more than 1.8 million workers in the United States suffer painful back and repetitive strain injuries,
More informationFigure 2.1: Glucose meter
CHAPTER TWO: MONITORING TECHNOLOGIES 2.1 Introduction Glucose monitoring is a method of self-testing glucose (blood sugar) levels for the management of diabetes. Traditionally, it involves pricking the
More informationDiclofenac And Triamcinolone Acetonide Impair Tenocytic Differentiation And Promote Adipocytic Differentiation Of Mesenchymal Stem Cells
Diclofenac And Triamcinolone Acetonide Impair Tenocytic Differentiation And Promote Adipocytic Differentiation Of Mesenchymal Stem Cells Maritha Fredriksson, Yan Li, Anders Stråman, Lars-Arne Haldosen,
More informationACPOMIT Conference 2013 Workshop: Hand and Wrist
ACPOMIT Conference 2013 Workshop: Hand and Wrist Sarah Turner, MCSP, Clinical Specialist in Hand Therapy Grad Dip Injection Therapy Workshop! Trigger Finger! OA 1 st CMC joint! De Quervain s Tenosynovitis!
More informationInsulin Pumps - External
Insulin Pumps - External Policy Number: Original Effective Date: MM.01.004 04/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/20174/1/2018 Section: DME Place(s) of
More informationThe Journal of Rheumatology Volume 33, no. 10. Lateral epicondylitis in general practice: course and prognostic indicators of outcome.
The Journal of Rheumatology Volume 33, no. 10 Lateral epicondylitis in general practice: course and prognostic indicators of outcome. Nynke Smidt, Martyn Lewis, Daniëlle A W M VAN DER Windt, Elaine M Hay,
More informationCommon Hand Conditions Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives
NHS Dorset Clinical Commissioning Group Common Hand Conditions Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives POLICY TRAIL AND VERSION CONTROL SHEET: Policy Reference:
More informationMSK INJECTION THERAPY
MSK INJECTION THERAPY MATS 2017 AIMS and Objectives Brief overview of Injection therapy, assessment tips and advice Small group work in 3 rotating groups. Use models and GLOVES (please take a pair round
More information123 Are You Providing Evidence-Based Diabetes Care? - Martin
Donna Martin, DNP, RN, CDE, CMSRN Lewis University Learner will be able to: Identify current inpatient standards of care for patients with diabetes Describe causes of hyperglycemia / hypoglycemia in the
More informationSubacromial Bursa Injection
Subacromial Bursa Injection 5 cc syringe, 21 gauge 1.5 inch needle 1% lidocaine - 4cc 40mg triamcinolone - 1 cc of 40mg/ml identify site-seat the patient with weight of arm hanging down, palpate the lateral
More informationWelcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1
Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies
More informationThis is a repository copy of Psoriasis flare with corticosteroid use in psoriatic arthritis.
This is a repository copy of Psoriasis flare with corticosteroid use in psoriatic arthritis. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/98736/ Version: Accepted Version
More informationInjectable Corticosteroids in Modern Practice
Brian J. Cole, MD, MBA, and H. Ralph Schumacher, Jr, MD Abstract Long-lasting, crystalline suspensions of injectable corticosteroids have been used to treat joint and soft-tissue disorders for many years;
More informationTimely!Insulinization In!Type!2! Diabetes,!When!and!How
Timely!Insulinization In!Type!2! Diabetes,!When!and!How, FACP, FACE, CDE Professor of Internal Medicine UT Southwestern Medical Center Dallas, Texas Current Control and Targets 1 Treatment Guidelines for
More informationHBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT
Basrah Journal Of Surgery Bas J Surg, September, 18, 2012 HBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT MB,ChB, DA, FICMS, Lecturer in Anesthesiology, Department of Surgery, College of Medicine,
More informationContinuous Glucose Monitoring System
Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 4/1/2018 Section: DME Place(s)
More informationOveruse Injuries of the Upper Extremity. Overuse Injuries 7/23/2018. Peadiatric Overuse Sports Injuries. Al Hess, MD
Overuse Injuries of the Upper Extremity Al Hess, MD 7/21/2018 1 Overuse Injuries Everything? Not Trauma, infection, tumor, rheumatoid arthritis, osteoarthritis Onset of pain associated with repetitive
More informationKAPA 2017 Musculoskeletal Aspiration and Injection Workshop. W. Scott Black, MD Physician Assistant Studies Program University of Kentucky
KAPA 2017 Musculoskeletal Aspiration and Injection Workshop W. Scott Black, MD Physician Assistant Studies Program University of Kentucky Aspiration Relatively quick and inexpensive Can be performed in
More informationTrauma & Orthopaedic Undergraduate Syllabus
Trauma & Orthopaedic Undergraduate Syllabus Introduction The purpose of this document is to provide a recommended syllabus for medical students in Trauma & Orthopaedics (T&0). It should help students on
More informationSYNOPSIS. Administration: subcutaneous injection Batch number(s):
SYNOPSIS Title of the study: A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top
More informationYour Orthopaedic Experience: Bones, Muscles and Joints. Getting you back into motion
Your Orthopaedic Experience: Bones, Muscles and Joints Getting you back into motion Taking on your aches and pains You want to enjoy all life has to offer. And it s when you re mobile and active, and your
More informationDemographic Trends and Complication Rates in Arthroscopic Elbow Surgery
Demographic Trends and Complication Rates in Arthroscopic Elbow Surgery Natalie L. Leong 1 *, Jeremiah R. Cohen 1, Elizabeth Lord 1, Jeffrey C. Wang 2, David R. McAllister 1, and Frank A. Petrigliano 1
More informationContinuous Glucose Monitoring
Continuous Glucose Monitoring What is Continuous Glucose Monitoring? Blood glucose meters measure glucose in your blood and glucose sensors measure glucose levels in the fluid around the cells They are
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationShort-Term Outcome of Combined Corticosteroid and Local Anaesthetic Therapy with Home-Based Exercıse Programme in Painful Shoulder Conditions
Adisa et al Tropical Journal of Pharmaceutical Research, December 2008; 7 (4): 1123-1127 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved.
More informationYour Orthopaedic Experience: Bones, Muscles and Joints. Getting you back into motion. Hospitals + Health Checks + Physio + Gyms
Your Orthopaedic Experience: Bones, Muscles and Joints. Getting you back into motion. Hospitals + Health Checks + Physio + Gyms Taking on your aches and pains. Getting you mobile your way. You want to
More informationNHS Fylde and Wyre Clinical Commissioning Group. Policies for the Commissioning of Healthcare. Policy for surgical treatment of carpal tunnel syndrome
NHS Fylde and Wyre Clinical Commissioning Group Policies for the Commissioning of Healthcare Policy for surgical treatment of carpal tunnel syndrome 1 Introduction 1.1 This document is part of a suite
More informationCorticosteroid injection in diabetic patients with trigger finger: A prospective, randomized, controlled double-blinded study
Washington University School of Meicine igital Commons@Becker Open Access Publications 12-1-2007 Corticosteroi injection in iabetic patients with trigger finger: A prospective, ranomize, controlleouble-bline
More informationCase Study. Patient Profile. Baseline Report - Daily Patterns. Insights
Case Study Patient Profile Sex/Age: Male, elderly Disease diagnosis: Type 2 for the past 30 years, recurrent episodes of hunger HbA1c: 6.2% Diabetes medication profile: DPP-4 inhibitor 50 mg twice a day,
More informationICD-10 CM Training. Orthopaedic
ICD-10 CM Training Orthopaedic ICD-10-CM Compliance Dates ICD-10-CM will be valid for dates of service on or after October 1, 2015 Outpatient dates of service of October 1, 2015 and beyond. Inpatient hospital
More informationContinuous Glucose Monitoring System
Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2016 Section: DME Place(s)
More informationSteroid intra-articular injections for foot and ankle conditions: How effective are they?
The Foot and Ankle Online Journal Official Publication of the International Foot & Ankle Foundation faoj.org / ISSN 1941-6806 Steroid intra-articular injections for foot and ankle conditions: How effective
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationBarriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia. KM Pantalone Endocrinology
Barriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia KM Pantalone Endocrinology Disclosures Speaker Bureau AstraZeneca, Merck, Novo Nordisk, Sanofi Consultant Novo Nordisk, Eli Lilly, Merck
More informationPractical guide to joint and soft tissue injection techniques James Galloway MRCP and Marwan Bukhari PhD, FRCP
Practical guide to joint and soft tissue injection techniques James Galloway MRCP and Marwan Bukhari PhD, FRCP Figure 1. The authors encourage a medial approach to injection of the knee joint; a combination
More informationUsefulness of Ambulatory Glucose Profile (AGP) in Diabetes Care
C H A P T E R 41 Usefulness of Ambulatory Glucose Profile (AGP) in Diabetes Care K Chaithanya Murthy, B Ramya, E Vidya, RM Anjana, V Mohan ABSTRACT Over the past decades, several newer technologies have
More informationWorkstation Wellness. Objectives. Purpose of the Project 6/3/2015. Sip Stand Stretch. At the end of the presentation, the participant will be able to
Workstation Wellness Sip Stand Stretch Objectives At the end of the presentation, the participant will be able to Discuss the health implications of prolonged sitting. Identify personal interventions that
More information13/02/2011. Ergonomics
13/02/2011 Ergonomics Workplace Safety Electrical Safety Medical & First Aid Lockout/Tag-out Confined Space Asbestos Control Fire Prevention Personal Protective Equipment Hazard Communication Chemical
More informationTransition of Care in Hospitalized Patients with Hyperglycemia and Diabetes
Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Critically ill patients in the ICU Hospital Non-ICU Settings Home Guillermo E Umpierrez, MD, FACP, FACE Professor of Medicine
More informationWe performed a prospective, randomised trial on
LOCAL CORTICOSTEROID INJECTION VERSUS CYRIAX-TYPE PHYSIOTHERAPY FOR TENNIS ELBOW J. A. N. VERHAAR, G. H. I. M. WALENKAMP, H. VAN MAMEREN, A. D. M. KESTER, A. J. VAN DER LINDEN From the University Hospital,
More informationMORE FOR BACKS PROGRAM. User guide for osteopaths and osteopathy code list (ICD-10-AM codes)
MORE FOR BACKS PROGRAM User guide for osteopaths and osteopathy code list (ICD-10-AM codes) APRIL 2017 WELCOME TO THE MORE FOR BACKS PROGRAM This program reimburses 100% of the agreed charge for an initial
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Agenda Association between Cardiovascular Disease and Type 2 Diabetes Importance of HbA1c Management esp. High risk patients
More informationStudy selection Study designs of evaluations included in the review Diagnosis.
Diagnosis and treatment of worker-related musculoskeletal disorders of the upper extremity: epicondylitis Chapell R, Bruening W, Mitchell M D, Reston J T, Treadwell J R Authors' objectives The objectives
More informationPhysical Activity/Exercise Prescription with Diabetes
Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity
More informationINSULIN THERAPY. Rungnapa Laortanakul, MD Maharat Nakhon Ratchasima hospital
INSULIN THERAPY Rungnapa Laortanakul, MD Maharat Nakhon Ratchasima hospital 3 Sep. 2013 Case Somsak is a 64-year-old man was diagnosed with T2DM, HT, and dyslipidemia 9 years ago. No history of hypoglycemia
More informationSponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More informationSafe Treatment of Trigger Thumb With Longitudinal Anatomic Landmarks
Safe Treatment of Trigger Thumb With Longitudinal Anatomic Landmarks Ron Hazani, MD, Josh Elston, BS, Ryan D. Whitney, BS, Jeremiah Redstone, MD, Saeed Chowdhry, MD, and Bradon J. Wilhelmi, MD Division
More informationMORE FOR BACKS PROGRAM. User guide for chiropractors and chiropractic code list (ICD-10-AM codes)
MORE FOR BACKS PROGRAM User guide for chiropractors and chiropractic code list (ICD-10-AM codes) APRIL 2017 WELCOME TO THE MORE FOR BACKS PROGRAM This program reimburses 100% of the agreed charge for an
More informationSwitching from insulin glargine to insulin degludec: Safety and efficacy in Colombian adolescents with type 1 diabetes
Diabetes Management Switching from insulin glargine to insulin degludec: Safety and efficacy in Colombian adolescents with type 1 diabetes Myrey Siuffi D* ABSTRACT Introduction: Degludec (Ideg) is an ultra-long
More informationCollege of Charleston PEHD 330 Kinesiology Spring Semester Credit Hours. Tu-Th 10:50-12: Johnson Center
College of Charleston PEHD 330 Kinesiology Spring 2011 3 Semester Credit Hours TIME & PLACE: INSTRUCTOR: OFFICE HOURS: OFFICE: Tu-Th 10:50-12:05-206 Johnson Center William R. Barfield, Ph.D., FACSM Professor
More informationHAP PA-HEN Achieving More Together
HAP PA-HEN Achieving More Together Managing Hyperglycemia in the Hospital: Strategies for Safe and Effective Care Pennsylvania Patient Safety Authority Managing Hyperglycemia in the Hospital: Strategies
More informationContinuous Glucose Monitoring System
Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017 Section: DME Place(s)
More informationDIABETES MANAGEMENT DISCHARGE COMMUNICATION (DM-DC) AUDIT TOOL
DIABETES MANAGEMENT DISCHARGE COMMUNICATION (DM-DC) AUDIT TOOL Facility: Date: Data Collector s name: Email/Phone: Purpose: To evaluate your facility practices regarding communication of requisite diabetes
More informationPeriarthropathies: Clinical Spectrum and Patterns
Bahrain Medical Bulletin, Vol. 3, No. 4, December 00 Periarthropathies: Clinical Spectrum and Patterns Farah K Sulaeman, MB, ChB* Wameedh RS Al-Omari, MB, ChB, FRCP** Zahraa A Al-Nuaimi, BSc, MSc*** Mohammed
More informationeplasty: Vol. 8 Anatomic Landmarks for the First Dorsal Compartment
eplasty: Vol. 8 Anatomic Landmarks for the First Dorsal Compartment Ron Hazani, MD, Nitin J. Engineer, MD, Damon Division of Plastic and Reconstructive Surgery, University of Louisville School of Medicine,
More informationThe impact of the Belgian workers compensation system on return to work after rotator cuff surgery
Acta Orthop. Belg., 2010, 76, 592-597 ORIGINAL STUDY The impact of the Belgian workers compensation system on return to work after rotator cuff surgery Karolien DiDDEN, Geert LEiRs, Peter AERts From Mariaziekenhuis,
More informationCorticosteroid injections for the treatment of hand and wrist disorders in general practice Peters-Veluthamaningal, Cyriac
University of Groningen Corticosteroid injections for the treatment of hand and wrist disorders in general practice Peters-Veluthamaningal, Cyriac IMPORTANT NOTE: You are advised to consult the publisher's
More informationPragmatic use of US in intraarticular and periarticular procedures
Pragmatic use of US in intraarticular and periarticular procedures Plovdiv, 13. January 2018 Dr. med. Giorgio Tamborrini-Schütz www.irheuma.com member of the EULAR Network of Imaging Training Centres Ulrasound
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationCorticosteroid Injection vs. Nonsteroidal Antiinflammatory Drug and Splinting in Carpal Tunnel Syndrome
Authors: Reyhan Çeliker, MD Şule Arslan, MD Fatma İnanıcı, MD Carpal Tunnel Syndrome Affiliations: From the Department of Physical Medicine and Rehabilitation, Hacettepe University School of Medicine,
More informationMORE FOR BACKS PROGRAM. User guide for chiropractors and chiropractic code list (ICD-10-AM codes)
MORE FOR BACKS PROGRAM User guide for chiropractors and chiropractic code list (ICD-10-AM codes) MAY 2018 WELCOME TO THE MORE FOR BACKS PROGRAM This program reimburses 100% of the agreed charge for an
More informationResults Of Tenosynovectomy And Intralesional Steroid In The Management Of Trigger Fingers
ISPUB.COM The Internet Journal of Orthopedic Surgery Volume 5 Number 1 Results Of Tenosynovectomy And Intralesional Steroid In The Management Of Trigger Fingers A Ogbemudia, A Bafor, E Edomwonyi Citation
More informationDrug Class Monograph
Drug Class Monograph Class: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors Drugs: Farxiga (dapagliflozin), Invokamet (canagliflozin/metformin), Invokana (canagliflozin), Jardiance (empagliflozin),
More informationThe Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
doi: 10.2169/internalmedicine.9013-17 Intern Med Advance Publication http://internmed.jp CASE REPORT The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone
More informationSafety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus Journal Club (May 2013) Sara Al-Sharhan, Pharm D intern-
More informationWrist and Hand Complaints
Wrist and Hand Complaints Charles S. Day, M.D., M.B.A. Chief, Hand & Upper Extremity Surgery St. Elizabeth s Medical Center Tufts University School of Medicine Primary Care Internal Medicine 2018 Outline
More informationJournal Club ICU
Journal Club 2018.9.4 ICU Crit Care Med. 2018 Aug;46(8):1224-1229 Introduction Stress hyperglycemia SH SH >124 mg/dl or >200 mg/dl Lancet 2009;373:1798. stress hyperglycemia Lancet 2009;373:1798. SH Critical
More information04-Sep-17. INERTIA a failure to initiate or modify treatment in a timely manner in people whose health is likely to improve with this modification
PROF MERLIN THOMAS DIAttitude Study INERTIA a failure to initiate or modify treatment in a timely manner in people whose health is likely to improve with this modification 13% immediately 41% of patients
More information